http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004123731-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c713790ce00813da2e6c6d57a29456
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-10
filingDate 2003-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4faf45126a1946471e50c8274f6ea0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52ef74b33a1d13a50c7cdb8173d50b98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4f11d319a528dfc7a08d47252be2409
publicationDate 2004-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2004123731-A
titleOfInvention Dioctyl sodium sulfosuccinate combination tablets
abstract PROBLEM TO BE SOLVED: To provide dioctyl sodium sulfosuccinate which is known as a laxative and is widely used. However, since it is a semi-solid substance, it is difficult to mix it as it is when mixing it into a solid preparation. An object of the present invention is to provide a solid preparation which does not cause a production obstacle even when a large amount of tablets are produced by a formulation containing dioctyl sodium sulfosuccinate. SOLUTION: The tablet is characterized by containing dioctyl sodium sulfosuccinate, light anhydrous silicic acid and magnesium stearate. [Selection diagram] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005255595-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007055969-A
priorityDate 2002-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11130662-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5799521-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02255613-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53249634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23673837
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226521028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407486090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87072582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525628
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177

Total number of triples: 42.